Welcome! We regret to inform you that the Injury Board National News Desk has been discontinued. Feel free to browse around and enjoy our previously published articles, or visit The Injury Blog Network for the latest in personal injury news.

News tagged with 'Acomplia'

Posted by Chrissie Cole
November 06, 2008 12:04 AM

Pfizer Inc is the latest drug maker to abandon an obesity treatment that works by blocking the receptors in the brain that makes people hungry after smoking marijuana.

Posted by Chrissie Cole
October 27, 2008 11:58 AM

The European Medicines Agency (EMEA) has recommended the suspension of Acomplia (rimonabant) from Sanofi-Aventis. The agency concluded that the benefits of Acomplia no longer outweigh its risks and marketing should be suspended across the European Union (EU).

About the National News Desk

Our mission is to seek the complete truth and provide a full and fair account of the events and issues that surround personal safety, accident prevention, and injury recovery.  We are committed to serving the public with honesty and integrity in these efforts.

Hurt in an accident? Contact InjuryBoard.com

Subscribe

RSS Feed

Add the National News Desk to your favorite RSS reader

Add to Google Reader Add to myYahoo Add to myMSN Add to Bloglines Add to Newsgator Add to Netvibes Add to Pageflakes